"In line with other #Arthrex cases, the #PTAB 's finding the #patent is unpatentable has been remanded back to the Acting Director for the limited purpose of determining whether review is warranted. The arguments, which appear copied verbatim from another appeal, were not raised below." https://www.unifiedpatents.com/insights/2021/10/17/unified-defeats-constitutional-arguments-arthrex-remand-granted
